Life Science & Biotech Deal Sourcing

Scientifically Screened Deal Flow for Investors

For venture capital firms, private equity funds, family offices, and corporate venture teams investing in life sciences.

Finding the right life science deal takes more than a database search. Many of the best opportunities are off-market, early, or buried inside a technical story that is hard to evaluate quickly.

KG-STEM Advisory Group finds the deals and gives you an informed first read on each one.

We source opportunities that fit your investment thesis and screen each one through both a scientific and a business lens, so your team spends its time only on the companies worth a closer look.

Venture Capital: Biotech & Life Science Startups

For VC investors, we source and evaluate early-stage biotech and life science startups, including academic spinouts and university-born technologies.

01 | Sourcing

We identify startups that match your stage, therapeutic area, modality, and geography, drawing on university technology transfer offices, research networks, accelerators, and founder relationships.

02 | Scientific Screen

We assess the strength of the science, the mechanism, the quality of the data, and the technical risks a non-specialist could miss.

03 | Market, IP & Competition

We look at the unmet need, competing approaches, comparable companies, and the strength of the intellectual property position.

04 | Clinical & Regulatory Path

We outline the likely development path, key value-inflection milestones, and the regulatory risks that could affect timing and capital needs.

Private Equity: Stable Life Science Businesses

For PE investors, we source and evaluate established, cash-generating life science companies, including:

  • Laboratory testing and analytical services companies

  • Equipment calibration, validation, and maintenance providers

  • Manufacturers and distributors of lab materials, reagents, and consumables

01 | Sourcing

We find owner-operated and founder-led businesses, including off-market companies, that fit your size, sector, and geography criteria.

02 | Business Screen

We review the service and product mix, customer base and concentration, recurring revenue, and available financial indicators.

03 | Operational & Regulatory Review

We assess accreditation and quality requirements (such as ISO 17025, CLIA, and FDA quality standards), technical staffing, and equipment needs, which can make or break value in technical businesses.

04 | Fit & Next Steps

We summarize why the business fits your thesis, the key risks, and the questions to answer in diligence.

What You Receive

  • A curated list of opportunities matched to your investment criteria

  • A concise one-page screen for each opportunity, covering the science or operations, market, risks, and our recommendation

  • Deeper evaluations on request for the opportunities you want to pursue

  • Regular pipeline updates, so you always know what is in the funnel

Who We Work With

  • Venture capital firms investing in biotech and life sciences

  • Private equity funds and independent sponsors

  • Angel groups and syndicates

  • Family offices

  • Corporate venture capital teams

  • Search fund investors and searchers

Why KG-STEM

Generalist deal teams often lack the scientific depth to quickly separate strong life science opportunities from weak ones, and specialist consultants can be slow and expensive. KG-STEM combines hands-on scientific experience with financial modeling and business training.

Our founder brings more than a decade of biotechnology and life-sciences experience, an M.S. in Biotechnology from Johns Hopkins University, and specialized valuation and due diligence expertise.

Engagements are offered on a flat-fee or retainer basis.

Let’s Talk About Your Thesis

Start with a free 30-minute consultation.

Tell us what you invest in and what a great deal looks like for your fund. We’ll discuss how we can help fill your pipeline.

KG-STEM Advisory Group provides research and advisory services. We are not a registered broker-dealer or investment adviser, and we do not negotiate, arrange, or execute securities transactions. Our work does not constitute legal, tax, or investment advice.

A person in a business suit using a tablet displaying bar and line graphs, with a pencil in hand, in a well-lit office setting.